BRPI0414633A - composto, composição de diagnóstico, método para a doagnose de doenças ou condições, e, kit - Google Patents
composto, composição de diagnóstico, método para a doagnose de doenças ou condições, e, kitInfo
- Publication number
- BRPI0414633A BRPI0414633A BRPI0414633-6A BRPI0414633A BRPI0414633A BR PI0414633 A BRPI0414633 A BR PI0414633A BR PI0414633 A BRPI0414633 A BR PI0414633A BR PI0414633 A BRPI0414633 A BR PI0414633A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- diagnostic composition
- doagnosis
- disease
- condition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTO, COMPOSIçãO DE DIAGNóSTICO, MéTODO PARA A DIAGNOSE DE DOENçAS OU CONDIçõES, E, KIT". Um composto radioativo tendo a fórmula (I) onde R¬ 1¬ e Ar são como definidos no relatório descritivo, sais farmaceuticamente aceitáveis destes, composições contendo tais compostos e os usos destes em diagnoses de condições em que o receptor nicotinico <244>~ 7~ está envolvido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50573103P | 2003-09-25 | 2003-09-25 | |
PCT/GB2004/004116 WO2005030778A1 (en) | 2003-09-25 | 2004-09-24 | Ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0414633A true BRPI0414633A (pt) | 2006-11-07 |
Family
ID=34393060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414633-6A BRPI0414633A (pt) | 2003-09-25 | 2004-09-24 | composto, composição de diagnóstico, método para a doagnose de doenças ou condições, e, kit |
Country Status (14)
Country | Link |
---|---|
US (1) | US7982038B2 (pt) |
EP (1) | EP1668016A1 (pt) |
JP (1) | JP4792393B2 (pt) |
KR (1) | KR20060102328A (pt) |
CN (1) | CN1856497A (pt) |
AU (2) | AU2004276061A1 (pt) |
BR (1) | BRPI0414633A (pt) |
CA (1) | CA2538705A1 (pt) |
IL (1) | IL174218A0 (pt) |
MX (1) | MXPA06003196A (pt) |
NO (1) | NO20061819L (pt) |
NZ (1) | NZ546414A (pt) |
WO (1) | WO2005030778A1 (pt) |
ZA (1) | ZA200602445B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813067A (en) * | 2006-05-17 | 2008-03-16 | Astrazeneca Ab | Nicotinic acetylcholine receptor ligands |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726189A (en) * | 1996-05-03 | 1998-03-10 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanes |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
MXPA04010190A (es) * | 2002-04-18 | 2005-02-03 | Astrazeneca Ab | Compuestos heterociclicos. |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
WO2004052889A1 (en) * | 2002-12-06 | 2004-06-24 | Pharmacia & Upjohn Company Llc | Compounds as radioligands for the diagnosis of disease |
US20050129610A1 (en) * | 2003-06-24 | 2005-06-16 | Johns Hopkins University | Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor |
-
2004
- 2004-09-24 CN CNA2004800277112A patent/CN1856497A/zh active Pending
- 2004-09-24 BR BRPI0414633-6A patent/BRPI0414633A/pt not_active IP Right Cessation
- 2004-09-24 NZ NZ546414A patent/NZ546414A/en unknown
- 2004-09-24 JP JP2006527486A patent/JP4792393B2/ja not_active Expired - Fee Related
- 2004-09-24 KR KR1020067005816A patent/KR20060102328A/ko not_active Application Discontinuation
- 2004-09-24 MX MXPA06003196A patent/MXPA06003196A/es unknown
- 2004-09-24 EP EP04768659A patent/EP1668016A1/en not_active Withdrawn
- 2004-09-24 US US10/573,133 patent/US7982038B2/en not_active Expired - Fee Related
- 2004-09-24 AU AU2004276061A patent/AU2004276061A1/en not_active Abandoned
- 2004-09-24 CA CA002538705A patent/CA2538705A1/en not_active Abandoned
- 2004-09-24 WO PCT/GB2004/004116 patent/WO2005030778A1/en active Application Filing
-
2006
- 2006-03-09 IL IL174218A patent/IL174218A0/en unknown
- 2006-03-24 ZA ZA200602445A patent/ZA200602445B/en unknown
- 2006-04-25 NO NO20061819A patent/NO20061819L/no not_active Application Discontinuation
-
2009
- 2009-02-27 AU AU2009200802A patent/AU2009200802A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2009200802A1 (en) | 2009-03-19 |
NZ546414A (en) | 2009-07-31 |
AU2004276061A1 (en) | 2005-04-07 |
IL174218A0 (en) | 2006-08-01 |
US7982038B2 (en) | 2011-07-19 |
EP1668016A1 (en) | 2006-06-14 |
KR20060102328A (ko) | 2006-09-27 |
US20070172420A1 (en) | 2007-07-26 |
ZA200602445B (en) | 2007-09-26 |
JP4792393B2 (ja) | 2011-10-12 |
CA2538705A1 (en) | 2005-04-07 |
MXPA06003196A (es) | 2006-06-23 |
WO2005030778A1 (en) | 2005-04-07 |
CN1856497A (zh) | 2006-11-01 |
NO20061819L (no) | 2006-06-26 |
JP2007506719A (ja) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0606321A2 (pt) | tetraidropiridinas 3,4,(5)-substituìdas | |
NO20080728L (no) | Nye 1,4-benzotiazepin-1,1-dioksidderivater som har forbedrede egenskaper, fremgangsmate for fremstilling derav, medikamenter inneholdende nevnte forbindelsene og anvendelse derav | |
NO20080789L (no) | 1,4-benzotiazepin 1,1-dioksidderivater, fremgangsmate for fremstilling derav, medikamenter inneholdende denne forbindelsen og anvendelse derav som et hypolipid | |
BR0308816A (pt) | Tiazolidina-4-carbonitrilas e análogos e seus usos como inibidores da dipeptil-peptidas | |
BR9808513A (pt) | Composto, composição farmacêutica, método para tratamento de infecções por hiv e kit farmacêutico. | |
BRPI0610205A2 (pt) | piperidinas 3,4-substituìdas como inibidores da renina | |
BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
NO20045486L (no) | Nye forbindelser og deres anvendelse | |
BRPI0415613A (pt) | novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8 | |
BR0113039A (pt) | Composto ou um seu sal ou solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um indivìduo humano ou animal com uma condição antiinflamatória e/ou alérgica, e, processo para preparar um composto | |
NO20085004L (no) | Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler | |
BRPI0412343A (pt) | derivados de piridazina e seu uso como agentes terapêuticos | |
NO20052496L (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og anvendelse derav som medikamenter. | |
EP1547996A4 (en) | DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING | |
NO20052633L (no) | Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases | |
BRPI0414514A (pt) | uso de um composto, composto, e, composições farmacêuticas | |
NO20064412L (no) | Kondensert heterocykelderivat, medisinsk sammensetning inneholdende det samme og medisinsk anvendelse derav | |
NO20050134L (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
BRPI0413695A (pt) | derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas | |
BRPI0510274B8 (pt) | uso de um agente para tratar ou prevenir doença celíaca, composição farmacêutica compreendendo dito agente, método de diagnóstico de doença celíaca, ou suscetibilidade à doença celíaca, uso do dito agente para a preparação de um meio de diagnóstico e kit para realizar o dito método de diagnóstico | |
BRPI0111596B8 (pt) | Composto piridona, processo de produção do composto, composição farmacêutica, e uso do dito composto | |
EA200300507A1 (ru) | Радиофармацевтические агенты для диагностики болезни альцгеймера | |
WO2007006534A3 (en) | Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity | |
BRPI0808503B8 (pt) | composto, uso de um composto, e, composição farmacêutica | |
NO20040881L (no) | Orale antidiabetes midler. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |